August 04, 2019
1 min watch
Save

VIDEO: Treat wet AMD patients early to maintain best vision

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the American Society of Retina Specialists meeting, David S. Boyer, MD, discusses his presentation comparing anatomical and visual results from the HARBOR study of ranibizumab for the treatment of neovascular age-related macular degeneration.